Association between High Antitumor Activity of Oxaliplatin and Cyclophosphamide and Constitutional GSTM1 Homozygous Deletion in an Advanced Ovarian Cancer Patient

Publisher： Karger

E-ISSN： 1421-9794|59|4|290-293

ISSN： 0009-3157

Source： Chemotherapy, Vol.59, Iss.4, 2014-01, pp. : 290-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synergistic Antitumor Activity of Oxaliplatin in Combination with Gemcitabine in Pancreatic Tumor-Bearing Mice

By  

Chemotherapy, Vol. 53, Iss. 3, 2007-03 ,pp. : 153-159

Karger

Access to resources Recommend Favorite

A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study

By  

Chemotherapy, Vol. 61, Iss. 1, 2015-0 ,pp. : 15-22

Karger

Access to resources Recommend Favorite

The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses

By Wang Chunpeng   Liang Zhenzhen   Liu Xin   Zhang Qian   Li Shuang  

International Journal of Environmental Research and Public Health, Vol. 13, Iss. 11, 2016-11 ,pp. : 1138-1138

MDPI

Access to resources Recommend Favorite

Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity

By Hargadon Kristian M.  

Journal of Clinical Medicine, Vol. 5, Iss. 9, 2016-08 ,pp. : 76-76

MDPI

Access to resources Recommend Favorite

High Levels of KAP1 Expression Are Associated with Aggressive Clinical Features in Ovarian Cancer

By Cui Yanfen   Yang Shaobin   Fu Xin   Feng Jingwen   Xu Shilei   Ying Guoguang  

International Journal of Molecular Sciences, Vol. 16, Iss. 1, 2014-12 ,pp. : 363-377

MDPI

Access to resources Recommend Favorite